Health Care: Drugs

Acasti Pharma Inc (ACST: NASDAQ)

$1.03 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.03
52 Week High 2.55
52 Week Low 0.80
Avg. Daily Vol. (Mil) 0.37
Beta (3 year) -0.12
Share Related Items
Mkt Cap (Mil) 109.45
Shares Out (Mil) 106.26
Float (Mil) 103.40
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 12.60
Current Ratio 13.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 220.23
Price/Book 3.35
Price/Cash Flow -20.40
Per Share Data
Earnings -0.09
Sales 0.00
Book Value 0.31
Cash Flow -0.05
Business Summary
Acasti Pharma Inc is a biotechnology company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
General Information
545 Promenade du Centropolis
Suite 100
Laval, QC H7T 0A3
www.acastipharma.com
Industry : Drugs
Sector: Health Care
Employees: NA
CEO: Henri Harland
Short Interest
Current Month (Mil) 0.07
Previous Month (Mil) 0.10
Short Interest Ratio (Days) 0.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -18.20
Return on Investments -22.50
Profitability
Gross Margin 42.60
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter